Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the 6 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 103 people, planned
- Started
- 20 Feb 2024
- Expected to end
- Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Transcutaneous Cervical Vagal Nerve Stimulation
- Sham Stimulation
- [F-18]Fallypride
- Record updated
- 27 March 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Meet criteria for OUDs based on the DSM5 criteria
- Willing to undergo supervised withdrawal
- Willing to be transitioned to a MOUD or behavioral management during treatment aftercare
Who cannot take part
- Current treatment with methadone, naltrexone, or Suboxone or medications that would be contraindicated with hydromorphone or clonidine administration
- History of meningitis
- History of head trauma resulting in loss of consciousness (LOC) of greater than one minute where the LOC is not judged to be primarily related to overdose in the judgment of the study physician
- Past year moderate to severe non-opioid use disorders that would require separate withdrawal management
- Current or lifetime history of schizophrenia, schizoaffective disorder, or bulimia
- History of shrapnel or other foreign bodies that would preclude MRI scanning
- Positive test for COVID-19
- History of serious medical or neurological illness or organic mental disorder, including liver disease, but also including cardiovascular, gastrointestinal, hepatic, renal, neurologic, or other systemic illness, including liver enzymes aspartate transaminase (AST) and alanine transaminase (ALT) more than three times upper limit of normal, that would preclude involvement based on the clinical judgment of the study psychiatrist
- Positive pregnancy test or breastfeeding for women
- Traumatic brain injury
- Lack of venous access that would preclude PET imaging
- Active implantable device (i.e. pacemaker) or other VNS device exclusion
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in United States.
- 12 Executive Park DriveAtlanta, United StatesContact: James D Bremner, MDTaking people
- Emory UniversityAtlanta, United StatesContact: James D Bremner, MDTaking people
- Emory University Clinical Research NetworkAtlanta, United StatesContact: James D Bremner, MDTaking people
- Georgia Institute of TechnologyAtlanta, United StatesContact: James D Bremner, MDTaking people
- Health Sciences Research BuildingAtlanta, United StatesContact: James D Bremner, MDNot yet recruiting
- Rollins School of Public HealthAtlanta, United StatesContact: James D Bremner, MDTaking people
About the trial
What the trial wants to find out
This study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)? Eligible participants will be in the study for one week in an inpatient research hospital stay, have an MRI scan, and have a follow-up call 1-3 months after their inpatient stay. Participants will complete several psychiatric questionnaires/interviews, physiological monitoring with several devices, brain imaging, and VNS testing.
The 2 groups in the trial
- Transcutaneous Cervical Vagal Nerve Stimulation DeviceTreatment being tested
Stimulation with the tcVNS
Treatment: Transcutaneous Cervical Vagal Nerve Stimulation and [F-18]Fallypride
- Sham Stimulation DeviceSham treatment, for comparison
Stimulation with the sham device.
Treatment: Sham Stimulation and [F-18]Fallypride
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05834478, who can take part
- Record updated
- 27 March 2026